Dominic Esposito (@domespo) 's Twitter Profile
Dominic Esposito

@domespo

Protein expression guru, dabbler in drug discovery. professional golfer and poker player in my dreams

ID: 148720755

calendar_today27-05-2010 12:44:09

246 Tweet

167 Followers

298 Following

Dominic Esposito (@domespo) 's Twitter Profile Photo

Another success for rational structure-based vaccine design from the hands of Jason McLellan and colleagues at NIH. For once maybe viruses will start living in fear of us…

Dominic Esposito (@domespo) 's Twitter Profile Photo

Glad our team at @FredNatLab could play a small role in this excellent work—another great example of collaborative NIH science helping to fight the pandemic over the last 18 months.

Dominic Esposito (@domespo) 's Twitter Profile Photo

Great work by my colleagues at National Cancer Institute and @FredNatLab to explore the impact of mutations found in RASopathy diseases. And as always, ATUM synthetic genes make things so much easier...

Dominic Esposito (@domespo) 's Twitter Profile Photo

Well deserved aware to Kevan Shokat, who basically paved the way for every KRAS drug discovery effort in the last decade and demonstrated that the "undruggable" could actually be drugged.

Dominic Esposito (@domespo) 's Twitter Profile Photo

Well done to my colleagues Carissa Grose and Matthew Drew as well as the other FNLCR LDER recipients! Looking forward to some innovative science that will help improve our ability to produce recombinant proteins in the baculovirus-based insect cell system!

Dominic Esposito (@domespo) 's Twitter Profile Photo

McClintock's seminal work set the stage for the use of transposons as molecular biology tools as well. Transposition technology is the key to simple modification of baculovirus genomes to permit high-level production of recombinant proteins in insect cells. #TransposonDay2023

Lawrence Livermore National Laboratory (@livermore_lab) 's Twitter Profile Photo

A collaboration between the RAS Initiative @FredNatLab, Lawrence Livermore National Laboratory and BridgeBio Pharma resulted in the discovery of BBO-8520, which has recently cleared U.S. FDA's investigational new drug application. Explore the impact of BBO-8520 on mutant cancers: livermorelab.info/47lg05w